Associated noncardiac congenital anomalies among cases with congenital heart defects

Claude Stoll1, Beatrice Dott1, Yves Alembik1

  • 1Laboratoire de Genetique Medicale, Faculte de Medecine, Strasbourg, France.

Insights

Congenital heart defects (CHD) frequently co-occur with other anomalies. Approximately one in four infants with CHD present with associated major anomalies, necessitating comprehensive evaluation.

Area of Science:

  • Medical Genetics
  • Pediatric Cardiology
  • Reproductive Medicine

Background:

  • Congenital heart defects (CHD) are common birth anomalies.
  • Associated anomalies often accompany CHD, impacting patient management and outcomes.
  • Understanding the prevalence and types of these associated anomalies is crucial for clinical practice.

Purpose of the Study:

  • To determine the prevalence and spectrum of anomalies associated with congenital heart defects (CHD) in a population-based study.
  • To identify common patterns and types of co-occurring anomalies in infants with CHD.
  • To inform diagnostic and screening strategies for CHD cases.

Main Methods:

  • A population-based registry of congenital anomalies was utilized.
  • Data were collected over 26 years on live births, stillbirths, and terminations of pregnancy.
  • Analysis included 4005 cases with CHD and their associated anomalies.

Main Results:

  • The overall prevalence of CHD was 115.5 per 10,000 births.
  • 26.3% of CHD cases had associated major anomalies.
  • Common associated anomalies included chromosomal abnormalities (8.8%), recognized dysmorphic conditions (2.5%), and non-syndromic multiple congenital anomalies (15.0%).
  • Urinary tract, musculoskeletal, digestive, and central nervous system anomalies were most frequent.
  • Prenatal diagnosis was achieved in 18.7% of pregnancies with CHD.

Conclusions:

  • One in four infants with CHD have associated anomalies, highlighting the need for thorough investigation.
  • A significant proportion of CHD cases present with recognizable syndromes or patterns.
  • Routine screening for other anomalies in fetuses and infants with CHD is recommended.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
641
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
563
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
887
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K